ABBV-142

DRUG2 trials

Sponsors

AbbVie

Conditions

Healthy VolunteerIdiopathic Pulmonary Fibrosis

Phase 1

A Study to Assess the Adverse Events and How Subcutaneous (SC) Injections and Intravenous (IV) Infusions of ABBV-142 Move Through the Body of Healthy Adult Participants

CompletedNCT06774313

AbbVieHealthy Volunteer

Start: 2025-01-22End: 2026-04-08Updated: 2026-05-06

Phase 2

Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis

RecruitingNCT07230288

AbbVieIdiopathic Pulmonary Fibrosis

Start: 2026-01-23End: 2029-09-01Target: 165Updated: 2026-09-03